Pathological fibrous periosteum involvement of prostate cancer means that the cancer cells have invaded the fibrous periosteum, and if the invasion is to the outside, it belongs to local metastasis.
The so-called prostate peritoneum refers to a layer of dense fibromuscular mesenchyme around the periphery of the prostate gland, encircling the posterior surface of the prostate gland, and the peritoneum is an important symbol for the presence or absence of extra-glandular invasion of the prostate gland. Pathological fibrous peritoneum involvement of prostate cancer means that cancer cells invade the fibrous peritoneum, and there is a possibility of metastasis.
One of the metastatic pathways of prostate cancer is local metastasis and local spread. As the disease progresses, the tumor passes through the periprostatic membrane and invades the prostate and surrounding organs.
For prostate cancer without metastasis, surgery is the most common treatment. Surgical options include open surgery, laparoscopic surgery, or robotic surgery. For prostate cancer that has metastasized radiation therapy, hormone therapy (endocrine therapy), chemotherapy, and immunotherapy are usually used.
Prostate cancer is currently incurable, but it can be treated promptly and effectively to alleviate symptoms and prolong the patient’s life.